.jpg)
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
The decision is a setback for GLP-1 drugmakers, though it's not entirely surpris...
Art Garfunkel is breaking the sound of silence around his experience with plaque...
The Trump administration rejected a proposed rule to allow Medicare to cover blo...
PRAC recommendations on signals adopted at the 10-13 March 2025 meeting
Duality Biologics has begun offering stock, wading into a market routed by Trump...
Medicine shortage communication (MSC): Mimpara (cinacalcet)
Human medicines European public assessment report (EPAR): Azacitidine Mylan, aza...
Human medicines European public assessment report (EPAR): Elrexfio, elranatamab,...
U.K.-based Epsilogen has bought Boston biotech TigaTx with the aim of creating “...
Human medicines European public assessment report (EPAR): Tivdak, tisotumab vedo...
Facing “build versus buy,” or “rent versus own” for integration? Get a guide to ...
NashBio is transforming life sciences by making complex genomic and real-world d...
Tapping into Henry Winkler’s status as a beloved Hollywood icon has majorly paid...
GSK has continued to flesh out its neuroscience strategy with a 2 billion pound ...
The right message served to the right patient sounds great, but even that pairin...
Orphan designation: single guide RNA containing a sequence complementary to huma...
Orphan designation: povetacicept Treatment of primary IgA nephropathy, 25/03/202...
Quality Innovation Group (QIG) Listen and Learn Focus Group (LLFG) meeting on pe...
Eli Lilly has sued Indianapolis-based spa Premier Weight Loss, claiming it buys ...
Orphan designation: extract from Cannabis flower, containing high levels of cann...
Orphan designation: allopurinol Treatment of Marfan syndrome, 25/03/2025 Positive